Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Etoposide × 30 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 12 Lymphoma, Large B-Cell, Diffuse 6 Lung Neoplasms 5 Burkitt Lymphoma 5 Recurrence 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Hodgkin Disease 4 Sarcoma, Ewing 3 Neoplasms 3 Lymphoma 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Teratoma 2 Sarcoma 2 Rhabdoid Tumor 2 Neuroendocrine Tumors 2 Neoplasms, Germ Cell and Embryonal 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Ependymoma 2 Carcinoma, Embryonal 2 Waldenstrom Macroglobulinemia 1 Vasculitis, Central Nervous System 1 Urologic Neoplasms 1 Thyroid Neoplasms 1 Stiff-Person Syndrome 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Small Cell Lung Cancer Extensive Stage 1

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡